Recent Headlines
Pennington Biomedical Welcomes Dr. Stefan Pasiakos as Director of the Center for Human Performance Optimization
Dr. Stefan Pasiakos has joined the faculty as Professor and Director of Human Performance Optimization at Pennington Biomedical Research Center in Baton Rouge, LA. - May 11, 2025 - Pennington Biomedical Research Center
Prehistoric "Transformer Scorpion" Discovered - CT Scan Provided by Advanced Amber
A team of scientists in France and Myanmar have discovered a new species of prehistoric scorpion and published it as a holotype. - May 09, 2025 - Advanced Amber
Pennington Biomedical Researchers Highlight How Cellular Quality Control Contribute to Insulin Resistance Related to Type 2 Diabetes
Study highlights the complex interplay between mitochondria and insulin, paving the way for future interventions aimed at improving metabolic health - May 07, 2025 - Pennington Biomedical Research Center
Industry-First Platform Combines AI-Powered Simulation and Lab Testing for Faster Biodegradation Assessment
Aropha's Biodegradation Studio is transforming how product developers approach biodegradability testing. The new platform combines rapid, AI-powered simulation with accredited laboratory services. Users can manage and accelerate every stage of biodegradability testing — from virtual screening to lab validation —through one, centralized hub. The studio helps R&D teams cut costs, screen more chemicals, speed up development and bring biodegradable materials to market faster. - May 06, 2025 - Aropha
Lawyers: Brazilian Bar Prepares New Edition of the Boston Mission for 2025
OAB (Brazilian Bar) Aparecida de Goiânia is organizing the 2025 Boston Mission, featuring visits to Harvard, MIT, the Brazilian Consulate, State House, and Chamber of Commerce. The initiative promotes legal internationalization through workshops and institutional meetings. Applications open in the second half of the year. - May 05, 2025 - Marco Alves
MindScape Retreat Releases Landmark Case Study Showing 70% Average Symptom Improvement in Parkinson’s Patients Following Ibogaine Treatment in Mexico
MindScape Retreat in Cozumel, Mexico has released a groundbreaking case study showing a 70% average improvement in Parkinson’s symptoms following a 14-day ibogaine therapy program. Among 30 patients, 52% symptom relief was seen by Day 4, with further gains by Day 14. A quarter of participants who continued microdosing post-retreat maintained or improved results. The therapy, using Ibogaine HCl and TA, showed strong safety and potential neuroregenerative benefits via GDNF activation. - May 02, 2025 - MindScape Retreat
Dr. Adithya Hari Joins Pennington Biomedical as Physician/Nuclear Oncologist, Adds to Center’s Strategic Expansion of Cancer Metabolism Program
Collaborative role partners with Mary Bird Perkins Cancer Center, Louisiana Cancer Research Center, LSU Health New Orleans and LSU LCMC Health Cancer Center. - May 02, 2025 - Pennington Biomedical Research Center
Pennington Biomedical Finds United States Sees Disproportionate Increase in Body Mass Index Rates of More Than 60
Published in medical journal The Lancet: Diabetes & Endocrinology, research study by Pennington Biomedical Research Center researchers lays out the largest relative increase in obesity rates between 2004 and 2023 occurred in BMI range of 60 kg/m2 or more. - May 01, 2025 - Pennington Biomedical Research Center
Pennington Biomedical Research Center Investigates Tirzepatide's Role in Weight Loss and Metabolic Health
Pennington Biomedical researchers included Dr. Eric Ravussin, Dr. Corby Martin, Dr. Robbie Beyl, Dr. Frank Greenway, and Dr. Guillermo Sanchez-Delgado. - April 26, 2025 - Pennington Biomedical Research Center
MindScape Retreat in Cozumel, Mexico, Offers Innovative Ibogaine Therapy to Address Long-Term SSRI Effects and Serotonin Syndrome Risks
MindScape Retreat in Cozumel, Mexico, offers medically supervised ibogaine treatment to help individuals safely discontinue SSRIs and address associated long-term effects, including the risk of serotonin syndrome. By promoting neuroplasticity and restoring neurotransmitter balance, ibogaine therapy at an Ibogaine Retreat called MindScape Retreat provides a holistic approach to mental health recovery in a serene and supportive environment. - April 25, 2025 - MindScape Retreat
Researchers from Pennington Biomedical Research Center, Baylor College of Medicine Uncover Mechanisms That Connect Hormones and Metabolic Adaptations in Lactation
The Metabolic Demands of Nursing Drive Hormonal Adaptations in Mothers - April 17, 2025 - Pennington Biomedical Research Center
DiabeticU Opens Nominations for the 2025 Diabetes Impact Award
DiabeticU has opened nominations for the 2025 Diabetes Impact Award, honoring those making a difference in diabetes care and advocacy. Nominations are open until July 31, with finalists announced October 1. Learn more at diabeticu.com/impact-award. - April 16, 2025 - DiabeticU
Quick Responses, 2nd Edition Launch
New Edition of QUICK Responses Offers Practical, Proven Tools for Reducing Misbehavior in Schools. QUICK Responses for Reducing Misbehavior and Suspensions: A Behavioral Toolbox for Classroom and School Leaders (2nd Ed.) offers school staff fast, effective tools to manage student behavior, reduce suspensions, and boost academic achievement. - April 08, 2025 - ABA Technologies, Inc.
Dr. Mike Chan: Leading the Future of Organ-Specific Stem Cell Therapies with Revolutionary Treatments in Regenerative Medicine
Dr. Mike Chan is a global leader in regenerative medicine, transforming lives with stem cells, exosomes, and peptides. His innovative treatments regenerate tissues, restore healing, and enhance vitality. Patients experience renewed hope, improved energy, and recovery from chronic conditions. His groundbreaking work is reshaping the future of healthcare. - March 28, 2025 - Dr. Mike Chan
LSU’s Pennington Biomedical Brings Science-Backed Childhood Obesity Prevention Into 32 Louisiana Schools, Preschools
Greaux Healthy is a comprehensive, new program supported by the State of Louisiana that translates 35 years of Pennington Biomedical research into practical tools to prevent and treat childhood obesity - March 27, 2025 - Pennington Biomedical Research Center
Accofrisk Platform Will Measure More Than 100 Health Parameters Remotely
Accofrisk has announced the global launch of its remote non-invasive health monitoring platform. - March 22, 2025 - Accofrisk
Visionary Entrepreneur and Telemedicine Pioneer Michael Gorton Surprises Readers with Thrilling Sci-Fi Sequel "Tachyon Tunnel 2," Launching March 10
Visionary entrepreneur and telemedicine pioneer Michael Gorton surprises readers with "Tachyon Tunnel 2," the thrilling sequel to his award-winning sci-fi novel. Launching March 10, the book follows Alex and the Tranquility team as they face the unstoppable Daklin Empire, rulers of the galaxy for 50 million years. Blending real physics with gripping adventure, Tachyon Tunnel 2 cements Gorton’s place as a master storyteller. Available in print, digital, and audiobook formats. - March 11, 2025 - Michael Gorton
eg technology Bolsters Global Presence with Appointment of Paul Anglim
eg technology Ltd. make key appointment as Paul Anglim joins the specialist product design, engineering and development consultancy as they continue their international expansion. - March 11, 2025 - eg technology Ltd
Accofrisk Has Started Developing Non-Invasive Pocket Devices for Health Monitoring
Accofrisk announced the start of development of pocket-sized wearable devices for non-invasive health monitoring. - March 07, 2025 - Accofrisk
The Linguistic Society of America Issues Statement: Four Reasons Why English Should Not be the Official Language of the United States
Grounded in empirical findings and history, the statement explains that the four stated premises of the Executive Order are inaccurate. The United States has always been a multilingual country, enforcing one official language can generate intense resistance and embolden discrimination against linguistic minorities, immigrants already value English and recognize its value in the workplace, and supporting multilingualism makes a nation and its people stronger. - March 06, 2025 - Linguistic Society of America
HistAI Unveils Groundbreaking SPIDER Initiative at HIMSS Conference
At the HIMSS Conference, HistAI announced the SPIDER Initiative, an open-source project set to become the largest supervised medical imaging dataset. The initiative will compile more than 50 millions of fully annotated images from 20 organs and 400 morphologies, advancing AI-driven diagnostics, precision medicine, and drug development. The first release includes more than 4 millions of images from 6K Whole Slide Images (WSIs) across Skin, Colorectal, and Thorax. Available starting today. - March 06, 2025 - HistAI
AI MINDSystems Foundation and GenoBank.io Announce Strategic Partnership at ETHDenver to Advance Decentralized Biobanking and Healthcare Innovation
AI MINDSystems and GenoBank.io partner at ETHDenver to advance decentralized biobanking. Integrating GenoBank.io’s BioNFT™ into the AI MINDSystems Trusted Data Ecosystem™ empowers individuals with control over their biosamples via ‘lockable’ NFTs. This collaboration aims to create secure, privacy-preserving solutions for digital biology, precision health, and research, using blockchain and Web3 technologies. They also plan to launch WISDOM Networks™ for data-driven healthcare transformation. - February 28, 2025 - AI MINDSystems Foundation
Pennington Biomedical Researchers Uncover Role of Hormone in Influencing Brain Reward Pathway and Food Preferences
Dr. Christopher Morrison led team in discovering regulating role of hormone FGF21 for brain reward pathways, research published in Molecular Metabolism - February 28, 2025 - Pennington Biomedical Research Center
Purity Health, LLC Announces Lora Harnack as New Chief Executive Officer
Purity Health, LLC has appointed Lora Harnack as its new Chief Executive Officer, with former CEO Rob Bramblett transitioning to President. Harnack, a Tennessee native with 30 years of healthcare leadership experience, has held executive roles in hospital administration, healthcare IT, and nonprofit organizations, most recently leading the Cumberland Pediatric Foundation. - February 21, 2025 - Purity Health, LLC
Pennington Biomedical Researchers Assemble Comprehensive History of Electronic Health Records
Published in the Journal of Medical Internet Research, Dr. Yun Shen and Dr. Gang Hu explore 25 years of electronic health records’ secondary purpose - the interoperability with research - February 21, 2025 - Pennington Biomedical Research Center
New Greaux Healthy Toolkit Empowers Healthcare Providers with Evidence-Based Strategies for Childhood Obesity Prevention and Treatment
Greaux Healthy—a public service initiative powered by Pennington Biomedical Research Center, in partnership with the State of Louisiana—is proud to announce the release of the Childhood Obesity Prevention, Evaluation and Treatment Toolkit, a comprehensive resource designed to equip... - February 21, 2025 - Pennington Biomedical Research Center
ABA Technologies Earns 2024 Great Place To Work Certification™
ABA Technologies, Inc. is proud to be Certified™ by Great Place To Work® for the first year. The prestigious award is based entirely on what current employees say about their experience working at ABA Technologies, Inc. This year, 83% of employees said it’s a Great Place To... - February 20, 2025 - ABA Technologies, Inc.
Pennington Biomedical Contributes to Study Advancing Medical Imaging on Body Fat and Muscle Distribution
Dr. Steven Heymsfield part of research group advancing 3D imaging and deep learning techniques. - February 06, 2025 - Pennington Biomedical Research Center
Access EETech’s 2024 Engineering Insights Report: An Electronics Industry Reveal of the Latest Trends and Insights
Engineering Insights Report (EIR), featuring over 4,500 highly qualified engineer responses worldwide. - January 22, 2025 - EETech Media
Pennington Biomedical Researchers Serve on Global Commission on Clinical Obesity
Commission goes that goes beyond BMI in defining obesity as a disease. - January 18, 2025 - Pennington Biomedical Research Center
Global Launch for Clinical Obesity Definition to be Held Jan. 16, Pennington Biomedical Serving as North American Satellite Hub
Three researchers from Pennington Biomedical served on the 56-member Lancet Commission on Clinical Obesity - January 16, 2025 - Pennington Biomedical Research Center
Purple Diamond Hosting Exclusive Webinar on Pharmaceutical Packaging Validation and Product Integrity
Purple Diamond, a leading ISO-accredited package testing lab, will host a free webinar on February 4, at 2 pm EST. "Protecting Pharma Integrity: The Science of Packaging Validation" will provide insights into testing methodologies and tools critical for ensuring pharmaceutical packaging safety and compliance. - January 16, 2025 - Purple Diamond Testing
New Hope for Couples Trying to Conceive: Ovarium Conception Kit Study Offers 52% Pregnancy Rate
Women-owned company Ovarium Conception invents and patents an all natural conception cup as a hormone-free, at-home option for those trying to conceive. Recent observational study reveals a 52% pregnancy rate using the Ovarium Conception Kit, rivaling pregnancy rates for more invasive medical procedures such as IUI and IVF. - January 08, 2025 - Ovarium Conception
DASH Diet Recognized as Best Heart-Healthy Diet, Ranks as Second-Best Diet Overall
The Dietary Approaches to Stop Hypertension, or DASH, Diet, developed in part by Pennington Biomedical Research Center scientists, has been recognized as the second-best diet overall and the best heart-healthy diet in the 2025 U.S. News & World Report Best Diets Rankings. - January 08, 2025 - Pennington Biomedical Research Center
Small Shifts for the New Year from Researchers at Pennington Biomedical
New Year’s Day provides a fresh start and is a time when people set goals and resolutions for the year ahead. Many of those will focus on healthy eating, exercise or mental health, but drastic lifestyle changes are hard to adopt and typically are challenging to sustain. Instead, researchers... - December 26, 2024 - Pennington Biomedical Research Center
Pennington Biomedical Celebrates Employees for Service Milestones
Fourteen employees recognized for 20 years or more of service at Pennington Biomedical. - December 23, 2024 - Pennington Biomedical Research Center
Pennington Biomedical Conducts Study to Test Efficacy of Diabetes Medication for Cancer-Related Weight Loss
Dr. Justin Brown of Pennington Biomedical invites patients with lung or gastrointestinal cancers to participate in National Cancer Institute-funded trial. - December 23, 2024 - Pennington Biomedical Research Center
Impact of Government Assistance, Housing, and Employment on Postpartum Maternal Health Across Income and Race
Stressful periods such as COVID-19, hurricanes or infant formula shortages negatively impact racial groups differently. - December 13, 2024 - Pennington Biomedical Research Center
EBM Technologies and OmniPACS Partner to Transform Medical Imaging for Small to Medium Healthcare Providers in the US
EBM Technologies and OmniPACS are partnering to create accessible, AI-powered imaging solutions for U.S. healthcare providers. A pivotal meeting at MoMA inspired their creative vision for addressing challenges in medical imaging, blending EBM’s expertise with OmniPACS’s scalable platform. The partnership will debut innovations at RSNA 2024, focusing on solutions for small to medium healthcare facilities. - December 08, 2024 - OmniPACS Health Technologies LLC
The Role of Digital Technology in Diabetes Prevention and Management
Scientists at Pennington Biomedical Research Center, along with a colleague from Peking University People’s Hospital in China, have been leading a special collection and published an editorial in Frontiers in Endocrinology, emphasizing the transformative role digital health technologies play... - December 07, 2024 - Pennington Biomedical Research Center
Metabolic and Bariatric Surgery Safe and Effective for Patients with Severe Obesity
A multicenter examination of data demonstrates that for patients with a body mass index at or above 70 kg/m2 metabolic and bariatric surgery is a potent intervention. - December 07, 2024 - Pennington Biomedical Research Center
Dr. Stephanie Waldrop Joins Pennington Biomedical Research Center
New at Pennington Biomedical: Get to Know Dr. Stephanie Waldrop, assistant professor in Clinical Sciences - December 06, 2024 - Pennington Biomedical Research Center
Yael Freimann Named to NSBA Leadership Council
Yael Freimann of TI Verbatim Consulting (TIVC), was recently named to the National Small Business Association (NSBA) Leadership Council. NSBA is the nation’s oldest small-business advocacy organization, and operates on a staunchly nonpartisan basis. - December 02, 2024 - TI Verbatim Consulting
Harmonious Workplaces Announces New Cartoon Book: “Shermie the HR Hermit Crab”
Harmonious Workplaces has released “Shermie the HR Hermit Crab,” an 88-page cartoon book that tackles common workplace challenges with humor. Available on Amazon, this delightful book is ideal for HR professionals, managers, business executives, and anyone navigating the dynamics of modern workplaces. The book brings humor and heart to relatable scenarios. All ten comic strips end with a thoughtful lesson, making it both entertaining and insightful. - December 01, 2024 - Harmonious Workplaces
Pennington Biomedical Researchers Share Tips for the Holiday Season
From breakfast to holiday desserts, there are numerous ways to introduce small, manageable changes to your celebration. - November 20, 2024 - Pennington Biomedical Research Center
Let’s Win Pancreatic Cancer Selects TrialX to Launch Its First AI-Powered Global Clinical Trial Finder
Let’s Win Pancreatic Cancer, a go-to resource that guides patients and caregivers with vital information for better outcomes, launches a new global AI-based clinical trial finder - powered by TrialX - that aims to increase accessibility of clinical trial information for patients and families affected by pancreatic cancer. - November 19, 2024 - TrialX
Borderless Renewables Re-Emerges with Key Insights Into Decarbonised Electrification Policy Frameworks
After a period of focused scientific research, Borderless Renewables is re-emerging with pivotal insights into the policy frameworks essential for advancing decarbonised electrification. The global energy landscape is witnessing a rapid transformation, marked by the economic value of the... - November 07, 2024 - BorderlessRenewables
Rare Disease Foundation on the Road to Gene Therapy Brings Families to Fort Lauderdale from Around the World, November 15-17
The FOXG1 Research Foundation, the parent-led organization that is radically transforming the rare disease drug development landscape, is hosting an international conference in Fort Lauderdale from November 15-17, bringing families from across the globe together to learn about gene therapy advancements for FOXG1 syndrome. A highlight includes a presentation by 20-year-old Abraham Weitzman, who, though non-speaking, shares his lived experience using an innovative communication device. - November 04, 2024 - FOXG1 Research Foundation
GlycoMira Therapeutics Receives Key Patent for First-in-Class Oncology Therapeutic
Key patent covering GlycoMira's lead compound GM-1111 adds to the Company's already strong IP portfolio. - November 04, 2024 - GlycoMira Therapeutics, Inc.
Pennington Biomedical to be on Display at ObesityWeek 2024 in San Antonio
ObesityWeek is home to the latest developments in evidence-based obesity science. - November 02, 2024 - Pennington Biomedical Research Center